19 Analysts Have This To Say About Sage Therapeutics
19 Analysts Have This To Say About Sage Therapeutics
19個分析師對sage therapeutics發表了看法
Across the recent three months, 19 analysts have shared their insights on Sage Therapeutics (NASDAQ:SAGE), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月裏，19位分析師分享了他們對Sage Therapeutics（納斯達克：SAGE）的見解，表達了從看好到看淡各種觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Sage Therapeutics, presenting an average target of $19.63, a high estimate of $29.00, and a low estimate of $8.00. This current average has decreased by 22.32% from the previous average price target of $25.27.
在評估12個月的價格目標時，分析師揭示了Sage Therapeutics的見解，呈現了平均目標爲19.63美元，高估爲29.00美元，低估爲8.00美元。當前平均值比先前的平均價格目標$25.27下降了22.32％。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of...
通過對...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。